Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients

Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients

ABSTRACT Primary care urgently needs treatments for coronavirus disease 2019 (COVID-19) patients because current options are limited, while these patients who do not require hospitalization encompass more than 90% of the people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-...

Full description

Bibliographic Details
Main Authors: Ilke De Boeck, Eline Cauwenberghs, Irina Spacova, Thies Gehrmann, Tom Eilers, Lize Delanghe, Stijn Wittouck, Peter A. Bron, Tim Henkens, Imane Gamgami, Alix Simons, Ingmar Claes, Joachim Mariën, Kevin K. Ariën, Diana Bakokimi, Katherine Loens, Kevin Jacobs, Margareta Ieven, Patricia Bruijning-Verhagen, Peter Delputte, Samuel Coenen, Veronique Verhoeven, Sarah Lebeer
Format: Article
Language:English
Published: American Society for Microbiology 2022-10-01
Series:Microbiology Spectrum
Subjects:
COVID-19
lactobacilli
microbiome
throat spray
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01682-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.01682-22

Similar Items